site stats

Onco targets ther. impact factor

WebImpact factor 2.992 (2024) Five year impact factor 5 days Submission to first decision (Median) 328,202 (2024) Downloads. Latest issue. Volume 201. Issue 1, February 2024 View all volumes and issues. Latest articles. Peak Inspiratory Flow for Screening of Inspiratory Muscle Weakness in Neuromuscular Disease Authors (first, second and last … Web期刊名: Targeted Oncology 期刊名缩写: TARGET ONCOL 期刊ISSN: 1776-2596 E-ISSN: 1776-260X 2024年影响因子/JCR分区: 4.864/Q2 学科与分区: ONCOLOGY - SCIE (Q2) 出版国家或地区: FRANCE 出版周期: Quarterly 出版年份: 2006 年文章数: 70 是否OA开放访问: No Gold OA文章占比: 34.58% 官方网站: …

Targeted Oncology Home - Springer

Web10. apr 2024. · OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or precision therapy … WebOncoTargets and Therapy Citations: 737 An international, peer-reviewed journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment … ip32 7by https://heavenearthproductions.com

OncoTargets and Therapy Latest Journal Impact IF 2024-2024

Web30. sep 2024. · 例 えば、Oncotarget誌は2015年7月からBeall’s Listに掲載 (23) されつつもWeb of Scienceに収録されていた。 同誌は2016年版(2024年6月更新)までJournal Impact Factor(JIF)が腫瘍学分野で上位25%に入る有力誌だった (24) が、2024年の9巻4号を最後にWeb of Scienceでの収録が中止され (25) 、2024年版以降のJIFの対象外に … WebOncotarget Journal's Impact IF 2024 Prediction Oncotarget Journal's Impact IF Prediction System is now online. You can start share your valuable insights with the community. Journal's Impact IF Predition System Predict Check All Preditions 期刊出版物總量 25900 期刊累積被引用數 453992 出版物數量年度趨勢 期刊被引用量年度趨勢 國際合作趨勢 文獻 … Web21. apr 2009. · OncoTargets and Therapy 1178-6930 (Online) Website ISSN Portal About Articles Publishing with this journal The journal charges up to: 2836 USD as publication fees (article processing charges or APCs). There is a waiver policy for these charges. Look up the journal’s: Aims & scope Instructions for authors Editorial Board Anonymous peer review ip2x test probe

Meta-analysis of the impact of de novo and acquired EGFR T790M …

Category:Archive of "OncoTargets and Therapy". - PMC - National Center …

Tags:Onco targets ther. impact factor

Onco targets ther. impact factor

Oncotarget 2024-2024最新影響指數 - 實時趨勢預測 & 期刊影響力 …

Web27. maj 2024. · The impact score (IS) 2024 of OncoTargets and Therapy is 4.19, which is computed in 2024 as per its definition.OncoTargets and Therapy IS is increased by a … WebScope. OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted …

Onco targets ther. impact factor

Did you know?

Web05. apr 2024. · Targeted Oncology is a pragmatic tool for all physicians and scientists committed to oncology and cancer research. ... Impact factor 4.698 (2024) Five year impact factor 6 days Submission to first decision (Median) 160,127 (2024) Downloads. Latest issue. Volume 18. Issue 2, March 2024 WebOncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular …

WebOncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or … Web29. feb 2016. · Quality of life of patients with lung cancer Onco Targets Ther 2016 Feb 29;9:1023-8. doi: 10.2147/OTT.S100685. Authors Jacek Polanski 1 , Beata Jankowska-Polanska 2 , Joanna Rosinczuk 3 , Mariusz Chabowski 4 , Anna Szymanska-Chabowska 5 Affiliations 1 Lower Silesian Oncology Center, Home Hospice, Wroclaw Medical …

WebAn international, peer-reviewed journal focusing on the pathological basis of all cancers, potential targets for therapy and treatment protocols employed to improve the … Web13. apr 2016. · The purpose of this meta-analysis is to comprehensively summarize the effects of exercise intervention in breast cancer survivors. Methods: A systematic search …

Web22. mar 2016. · Onco Targets Ther. 2016 Mar 22;9:1679-88. doi: 10.2147/OTT.S95744. eCollection 2016. Authors Hui Shen 1 , Ming Zhan 1 , Wei Wang 1 , Dong Yang 1 , Jian Wang 1 Affiliation 1 Department of Biliary-Pancreatic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China. PMID: …

Web29. feb 2016. · Onco Targets Ther. 2016 Feb 29;9:1023-8. doi: 10.2147/OTT.S100685. eCollection 2016. ... It is affected by the severity and the number of symptoms such as … opening thirdWeb《Translational Oncology》发布于爱科学网,并永久归类相关SCI期刊导航类别中,本站只是硬性分析 "《TRANSL ONCOL》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。 opening the top of a maytag washerWebMolecular and Clinical Oncology is a monthly medical journal in the field of oncology that covers a wide range of original research, while offering a rapid publication process. The articles comprising each issue are carefully selected, peer-reviewed and revised to provide a wide variety of high-quality scientific research. Articles published in Molecular and … ip32 7beWebOncoTargets and Therapy is the 114 th out of 471 Oncology journals. This Journal is the 184 th out of 1,169 Pharmacology journals. This means the journal is among the top 16% in the discipline of Pharmacology. This Journal is the 1146 th out of 15,471 Health Sciences journals. This means the journal is among the top 8% in the science branch of ... opening thinkpad t400 laptopWeb17. jun 2024. · The c-MET proto-oncogene (MET) plays an important role in lung oncogenesis, affecting cancer-cell survival, growth and invasiveness. The MET receptor in non-small-cell lung cancer (NSCLC) is a potential therapeutic target. The development of high-output next-generation sequencing techniques has enabled better identification of … ip30 9hrWebOncoTargets Ther. OncoTargets and Therapy is a peer-reviewed medical journal covering research on all aspects of oncology. The journal was established in 2008 and is … ip33 3tb to ip14 1jlWeb24. apr 2024. · Meta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs Onco Targets Ther. 2024 Apr 24;10:2267-2279. doi: 10.2147/OTT.S133082. eCollection 2024. Authors ip 31 sailboats for sale